Skip to main content
Top
Published in: Supportive Care in Cancer 4/2015

01-04-2015 | Original Article

Dietary habits changes and quality of life in patients undergoing chemotherapy for epithelial ovarian cancer

Authors: Marcin Mardas, Małgorzata Jamka, Radosław Mądry, Jarosław Walkowiak, Marietta Krótkopad, Marta Stelmach-Mardas

Published in: Supportive Care in Cancer | Issue 4/2015

Login to get access

Abstract

Purpose

The aim of this study was to evaluate dietary habit changes in patients undergoing chemotherapy for epithelial ovarian cancer.

Methods

Sixty one patients undergoing chemotherapy for epithelial ovarian cancer were enrolled to the study and 44 completed. The dietary intake was evaluated by 7-day food records, and the changes in dietary intake and food-preparing methods were estimated based on a 101-item semiquantitative food frequency questionnaire. Nutritional status was checked with the use of body weight and height, waist and hip circumferences, skinfolds and subjective global assessment tool. Quality of life was measured with the use of EORTC QLQ-C30 and EORTC QLQ-OV28.

Results

Despite high average body mass index (BMI) (26.7–28.0 kg/m2), malnutrition risk was observed in 43.7 and 10.7 % of patients receiving first-line and subsequent-line chemotherapy, respectively (p < 0.001). Dietary intake and quality of life did not differ between the studied groups. A lot of dietary habits changes were observed. Women undergoing subsequent-line chemotherapy consumed more frequently rye bread, pasta, buttermilk, vegetable, fruit, oils, nuts, and juices. Women undergoing first-line chemotherapy consumed more milk, cottage cheese, cream, eggs, fish and seafood, meat offal, salty snacks, and jam. Additionally, women undergoing subsequent-line chemotherapy more often applied cooking in water (p < 0.0001) and baking (p < 0.05).

Conclusions

Women undergoing chemotherapy for ovarian cancer change their dietary habits in a pro healthy direction, and these changes are more expressed in patients undergoing subsequent-line chemotherapy.
Literature
1.
go back to reference Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray, F. (2013) GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Lyon, France: International Agency for Research on Cancer; Available from: http://globocan.iarc.fr. Accessed 24 Mar 2014 Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray, F. (2013) GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Lyon, France: International Agency for Research on Cancer; Available from: http://​globocan.​iarc.​fr. Accessed 24 Mar 2014
2.
go back to reference Reynolds EA, Moller KA (2006) A review and an update on the screening of epithelial ovarian cancer. Curr Probl Cancer 30:203–232CrossRefPubMed Reynolds EA, Moller KA (2006) A review and an update on the screening of epithelial ovarian cancer. Curr Probl Cancer 30:203–232CrossRefPubMed
3.
go back to reference Bookman MA (2010) The addition of new drugs to standard therapy in the first-line treatment of ovarian cancer. Ann Oncol. Suppl 7: vii211-17 Bookman MA (2010) The addition of new drugs to standard therapy in the first-line treatment of ovarian cancer. Ann Oncol. Suppl 7: vii211-17
4.
go back to reference Hall M, Gourley C, McNeish I, Ledermann J, Gore M, Jayson G, Perren T, Rustin G, Kaye S (2013) Targeted anti-vascular therapies for ovarian cancer: current evidence. Br J Cancer 108(2):250–258CrossRefPubMedCentralPubMed Hall M, Gourley C, McNeish I, Ledermann J, Gore M, Jayson G, Perren T, Rustin G, Kaye S (2013) Targeted anti-vascular therapies for ovarian cancer: current evidence. Br J Cancer 108(2):250–258CrossRefPubMedCentralPubMed
5.
go back to reference Stephenson LE, Bebb DG, Reimer RA, Culos-Reed SN (2009) Physical activity and diet behaviour in colorectal cancer patients receiving chemotherapy: associations with quality of life. BMC Gastroenterol 9:60CrossRefPubMedCentralPubMed Stephenson LE, Bebb DG, Reimer RA, Culos-Reed SN (2009) Physical activity and diet behaviour in colorectal cancer patients receiving chemotherapy: associations with quality of life. BMC Gastroenterol 9:60CrossRefPubMedCentralPubMed
6.
7.
go back to reference Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME (2004) Cancer: disease and nutrition are key determinants of patients’ quality of life. Support Care Cancer 12(4):246–252CrossRefPubMed Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME (2004) Cancer: disease and nutrition are key determinants of patients’ quality of life. Support Care Cancer 12(4):246–252CrossRefPubMed
8.
go back to reference Boltong A, Keast R (2012) The influence of chemotherapy on taste perception and food hedonics: a systematic review. Cancer Treat Rev 38(2):152–163CrossRefPubMed Boltong A, Keast R (2012) The influence of chemotherapy on taste perception and food hedonics: a systematic review. Cancer Treat Rev 38(2):152–163CrossRefPubMed
9.
go back to reference Boltong A, Keast R, Aranda S (2012) Experiences and consequences of altered taste, flavour and food hedonics during chemotherapy treatment. Support Care Cancer 20(11):2765–2774CrossRefPubMed Boltong A, Keast R, Aranda S (2012) Experiences and consequences of altered taste, flavour and food hedonics during chemotherapy treatment. Support Care Cancer 20(11):2765–2774CrossRefPubMed
10.
go back to reference Gupta D, Lis CG, Vashi PG, Lammersfeld CA (2010) Impact of improved nutritional status on survival in ovarian cancer. Support Care Cancer 18(3):373–381CrossRefPubMed Gupta D, Lis CG, Vashi PG, Lammersfeld CA (2010) Impact of improved nutritional status on survival in ovarian cancer. Support Care Cancer 18(3):373–381CrossRefPubMed
11.
go back to reference Sánchez-Lara K1, Sosa-Sánchez R, Green-Renner D, Rodríguez C, Laviano A, Motola-Kuba D, Arrieta O (2010) Influence of taste disorders on dietary behaviors in cancer patients under chemotherapy. Nutr J 9:15CrossRefPubMedCentralPubMed Sánchez-Lara K1, Sosa-Sánchez R, Green-Renner D, Rodríguez C, Laviano A, Motola-Kuba D, Arrieta O (2010) Influence of taste disorders on dietary behaviors in cancer patients under chemotherapy. Nutr J 9:15CrossRefPubMedCentralPubMed
12.
go back to reference Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern cooperative oncology group. Am J Clin Oncol 5:649–655CrossRefPubMed Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern cooperative oncology group. Am J Clin Oncol 5:649–655CrossRefPubMed
13.
go back to reference Jarosz M, Bułhak-Jachymczyk B (2008) Normy żywienia człowieka: podstawy prewencji otyłości i chorób niezakaźnych. PZWL, Warszawa Jarosz M, Bułhak-Jachymczyk B (2008) Normy żywienia człowieka: podstawy prewencji otyłości i chorób niezakaźnych. PZWL, Warszawa
14.
go back to reference Durnin JVGA, Womersley J (1974) Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 15 to 72 years. Brit J Nutr 32:77–97CrossRefPubMed Durnin JVGA, Womersley J (1974) Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 15 to 72 years. Brit J Nutr 32:77–97CrossRefPubMed
15.
go back to reference Laky B, Janda M, Cleghorn G, Obermair A (2008) Comparison of different nutritional assessments and body-composition measurements in detecting malnutrition among gynecologic cancer patients. Am J Clin Nutr 87(6):1678–1685PubMed Laky B, Janda M, Cleghorn G, Obermair A (2008) Comparison of different nutritional assessments and body-composition measurements in detecting malnutrition among gynecologic cancer patients. Am J Clin Nutr 87(6):1678–1685PubMed
16.
go back to reference Cristina M, Barbosa-Silvaa G, Barros AJD (2006) Indications and limitations of the use of subjective global assessment in clinical practice: an update. Curr Opin Clin Nutr Metab Care 9:263–269CrossRef Cristina M, Barbosa-Silvaa G, Barros AJD (2006) Indications and limitations of the use of subjective global assessment in clinical practice: an update. Curr Opin Clin Nutr Metab Care 9:263–269CrossRef
17.
go back to reference Zorlini R, Akemi Abe Cairo A, Salete Costa Gurgel M (2008) Nutritional status of patients with gynecologic and breast cancer. Nutr Hosp 23(6):577–583PubMed Zorlini R, Akemi Abe Cairo A, Salete Costa Gurgel M (2008) Nutritional status of patients with gynecologic and breast cancer. Nutr Hosp 23(6):577–583PubMed
18.
go back to reference Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JCJM, Kaasa S, Klee MC, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw KCA, Sullivan M, Takeda F (1993) The European Organisation for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376CrossRefPubMed Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JCJM, Kaasa S, Klee MC, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw KCA, Sullivan M, Takeda F (1993) The European Organisation for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376CrossRefPubMed
19.
go back to reference Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A, on behalf of the EORTC Quality of Life Group (2001) The EORTC QLQ-C30 scoring manual, 3rd edn. EORTC, Brussels Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A, on behalf of the EORTC Quality of Life Group (2001) The EORTC QLQ-C30 scoring manual, 3rd edn. EORTC, Brussels
20.
go back to reference Burgos R1, Sarto B, Elío I, Planas M, Forga M, Cantón A, Trallero R, Muñoz MJ, Pérez D, Bonada A, Saló E, Lecha M, Enrich G, Salas-Salvadó J, Group for the Study of Malnutrition in Hospitals in Catalonia (2012) Prevalence of malnutrition and its etiological factors in hospitals. Nutr Hosp 27(2):469–476PubMed Burgos R1, Sarto B, Elío I, Planas M, Forga M, Cantón A, Trallero R, Muñoz MJ, Pérez D, Bonada A, Saló E, Lecha M, Enrich G, Salas-Salvadó J, Group for the Study of Malnutrition in Hospitals in Catalonia (2012) Prevalence of malnutrition and its etiological factors in hospitals. Nutr Hosp 27(2):469–476PubMed
21.
go back to reference Moriana M, Civera M, Artero A, Real JT, Caro J, Ascaso JF, Martinez-Valls JF (2014) Validity of subjective global assessment as a screening method for hospital malnutrition. prevalence of malnutrition in a tertiary hospital. Endocrinol Nutr 61(4):184–189CrossRefPubMed Moriana M, Civera M, Artero A, Real JT, Caro J, Ascaso JF, Martinez-Valls JF (2014) Validity of subjective global assessment as a screening method for hospital malnutrition. prevalence of malnutrition in a tertiary hospital. Endocrinol Nutr 61(4):184–189CrossRefPubMed
22.
go back to reference Espahbodi F, Khoddad T, Esmaeili L (2014) Evaluation of malnutrition and its association with biochemical parameters in patients with end stage renal disease undergoing hemodialysis using subjective global assessment. Nephrourol Mon 15(6(3)):e16385 Espahbodi F, Khoddad T, Esmaeili L (2014) Evaluation of malnutrition and its association with biochemical parameters in patients with end stage renal disease undergoing hemodialysis using subjective global assessment. Nephrourol Mon 15(6(3)):e16385
23.
go back to reference Davies M (2005) Nutritional screening and assessment in cancer-associated malnutrition. Eur J Oncol Nurs 2:S64–S73CrossRef Davies M (2005) Nutritional screening and assessment in cancer-associated malnutrition. Eur J Oncol Nurs 2:S64–S73CrossRef
24.
go back to reference Pavelka JC, Brown RS, Karlan BY, Cass I, Leuchter RS, Lagasse LD, Li AJ (2006) Effect of obesity on survival in epithelial ovarian cancer. Cancer 107(7):1520–1524CrossRefPubMed Pavelka JC, Brown RS, Karlan BY, Cass I, Leuchter RS, Lagasse LD, Li AJ (2006) Effect of obesity on survival in epithelial ovarian cancer. Cancer 107(7):1520–1524CrossRefPubMed
25.
go back to reference Hutton JL, Baracos VE, Wismer WV (2007) Chemosensory dysfunction is a primary factor in the evolution of declining nutritional status and quality of life in patients with advanced cancer. J Pain Symptom Manag 33(2):156–165CrossRef Hutton JL, Baracos VE, Wismer WV (2007) Chemosensory dysfunction is a primary factor in the evolution of declining nutritional status and quality of life in patients with advanced cancer. J Pain Symptom Manag 33(2):156–165CrossRef
27.
go back to reference Ilow R, Regulska-Ilow B, Hudziec P, Cieślińska A (1996) Porównanie sposobu żywienia kobiet chorych na nowotwory sutka i jajnika oraz kobiet zdrowych. Część II: ilościowa ocena sposobu żywienia Żywienie Człow Metabol 23(1):47–54 Ilow R, Regulska-Ilow B, Hudziec P, Cieślińska A (1996) Porównanie sposobu żywienia kobiet chorych na nowotwory sutka i jajnika oraz kobiet zdrowych. Część II: ilościowa ocena sposobu żywienia Żywienie Człow Metabol 23(1):47–54
28.
go back to reference Lange E, Pyzalska M (2008) Ocena sposobu żywienia osób z chorobą nowotworową. Żywienie Człow Metabol 35(1):36–51 Lange E, Pyzalska M (2008) Ocena sposobu żywienia osób z chorobą nowotworową. Żywienie Człow Metabol 35(1):36–51
29.
go back to reference Enig B, Petersen HN, Smith DF, Larsen B (1987) Food preferences, nutrient intake and nutritional status in cancer patients. Acta Oncol 26(4):301–305CrossRefPubMed Enig B, Petersen HN, Smith DF, Larsen B (1987) Food preferences, nutrient intake and nutritional status in cancer patients. Acta Oncol 26(4):301–305CrossRefPubMed
30.
31.
go back to reference Thomson CA, Flatt SW, Rock CL, Ritenbaugh C, Newman V, Pierce JP (2002) Increased fruit, vegetable and fiber intake and lower fat intake reported among women previously treated for invasive breast cancer. J Am Diet Assoc 102(6):801–808CrossRefPubMed Thomson CA, Flatt SW, Rock CL, Ritenbaugh C, Newman V, Pierce JP (2002) Increased fruit, vegetable and fiber intake and lower fat intake reported among women previously treated for invasive breast cancer. J Am Diet Assoc 102(6):801–808CrossRefPubMed
32.
go back to reference Ilow R, Regulska-Ilow B, Hudziec P, Cieślińska A (1995) Porównanie sposobu żywienia kobiet chorych na nowotwory sutka i jajnika oraz kobiet zdrowych. Część I Zwyczaje żywieniowe i częstotliwość spożycia produktów spożywczych Żywienie Człow Metabol 22(4):335–350 Ilow R, Regulska-Ilow B, Hudziec P, Cieślińska A (1995) Porównanie sposobu żywienia kobiet chorych na nowotwory sutka i jajnika oraz kobiet zdrowych. Część I Zwyczaje żywieniowe i częstotliwość spożycia produktów spożywczych Żywienie Człow Metabol 22(4):335–350
33.
go back to reference Demark-Wahnefried W, Peterson B, McBride C, Lipkus I, Clipp E (2000) Current health behaviors and readiness to pursue life-style changes among men and women diagnosed with early stage prostate and breast carcinomas. Cancer 88(3):674–684CrossRefPubMed Demark-Wahnefried W, Peterson B, McBride C, Lipkus I, Clipp E (2000) Current health behaviors and readiness to pursue life-style changes among men and women diagnosed with early stage prostate and breast carcinomas. Cancer 88(3):674–684CrossRefPubMed
34.
go back to reference Salminen EK, Lagström HK, Heikkilä S, Salminen S (2000) Does breast cancer change patients’ dietary habits? Eur J Clin Nutr 54(11):844–848CrossRefPubMed Salminen EK, Lagström HK, Heikkilä S, Salminen S (2000) Does breast cancer change patients’ dietary habits? Eur J Clin Nutr 54(11):844–848CrossRefPubMed
35.
go back to reference Van Loon K, Wigler D, Niedzwiecki D, Venook AP, Fuchs C, Blanke C, Saltz L, Goldberg RM, Meyerhardt JA (2013) Comparison of dietary and lifestyle habits among stage III and metastatic colorectal cancer patients: findings from CALGB 89803 and CALGB 80405. Clin Colorectal Cancer 12(2):95–102CrossRefPubMedCentralPubMed Van Loon K, Wigler D, Niedzwiecki D, Venook AP, Fuchs C, Blanke C, Saltz L, Goldberg RM, Meyerhardt JA (2013) Comparison of dietary and lifestyle habits among stage III and metastatic colorectal cancer patients: findings from CALGB 89803 and CALGB 80405. Clin Colorectal Cancer 12(2):95–102CrossRefPubMedCentralPubMed
36.
go back to reference Meraner V, Gamper EM, Grahmann A, Giesinger JM, Wiesbauer P, Sztankay M, Zeimet AG, Sperner-Unterweger B, Holzner B (2012) Monitoring physical and psychosocial symptom trajectories in ovarian cancer patients receiving chemotherapy. BMC Cancer 28;12:77 Meraner V, Gamper EM, Grahmann A, Giesinger JM, Wiesbauer P, Sztankay M, Zeimet AG, Sperner-Unterweger B, Holzner B (2012) Monitoring physical and psychosocial symptom trajectories in ovarian cancer patients receiving chemotherapy. BMC Cancer 28;12:77
37.
go back to reference Greimel E, Daghofer F, Petru E (2011) Prospective assessment of quality of life in long-term ovarian cancer survivors. Int J Cancer 128(12):3005–3011CrossRefPubMed Greimel E, Daghofer F, Petru E (2011) Prospective assessment of quality of life in long-term ovarian cancer survivors. Int J Cancer 128(12):3005–3011CrossRefPubMed
38.
go back to reference Vetta F, Ronzoni S, Taglieri G, Bollea MR (1999) The impact of malnutrition on the quality of life in the elderly. Clin Nutr 18:259–267CrossRefPubMed Vetta F, Ronzoni S, Taglieri G, Bollea MR (1999) The impact of malnutrition on the quality of life in the elderly. Clin Nutr 18:259–267CrossRefPubMed
Metadata
Title
Dietary habits changes and quality of life in patients undergoing chemotherapy for epithelial ovarian cancer
Authors
Marcin Mardas
Małgorzata Jamka
Radosław Mądry
Jarosław Walkowiak
Marietta Krótkopad
Marta Stelmach-Mardas
Publication date
01-04-2015
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 4/2015
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-014-2462-2

Other articles of this Issue 4/2015

Supportive Care in Cancer 4/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine